JMS Co.,Ltd.
7702
Rank in Stocks
#21493
JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan,... JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.
Share Price
$2.72
Last synced: 2026-11-10
Market Cap
$66.77M
Change (1 day)
2.63%
Change (1 year)
-4.51%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade JMS Co.,Ltd. (7702)
Category
Healthcare
EPS for JMS Co.,Ltd. (7702)
EPS as of June 2026 TTM: $-0.18
According to JMS Co.,Ltd.'s latest financial reports, its current EPS (TTM) is $-0.18. At the end of 2025 the company had an EPS of $0.02, an increase over its 2024 EPS of $-0.01.
EPS history for JMS Co.,Ltd. from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.18 | -1,007.50% |
| 2025 | $0.02 | -349.48% |
| 2024 | $-0.01 | -111.20% |
| 2023 | $0.09 | -68.82% |
| 2022 | $0.28 | -56.75% |
| 2021 | $0.64 | -14.85% |
| 2020 | $0.75 | 75.90% |
| 2019 | $0.43 | 75.91% |
| 2018 | $0.24 | -44.03% |
| 2017 | $0.44 | 58.38% |
| 2016 | $0.27 | 478.74% |
| 2015 | $0.05 | -42.28% |
| 2014 | $0.08 | -86.81% |
| 2013 | $0.62 | 18.61% |
| 2012 | $0.53 | -27.10% |
| 2011 | $0.72 | -3.22% |
| 2010 | $0.75 | 34.46% |
| 2009 | $0.55 | 17.80% |
| 2008 | $0.47 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.37 | -4,711.57% |
US
|
|
| $6.02 | -3,417.85% |
FR
|
|
| $4.15 | -2,386.50% |
US
|
|
| $5.32 | -3,031.18% |
JP
|
|
| $1.29 | -810.74% |
CH
|
Questions about JMS Co.,Ltd.'s earnings per share (EPS)
What is JMS Co.,Ltd.'s earnings per share (EPS)?
JMS Co.,Ltd.'s earnings per share (EPS) over the last twelve months is $-0.18, as of Jun 2026.
What was JMS Co.,Ltd.'s earnings per share (EPS) in 2025?
In 2025, JMS Co.,Ltd.'s earnings per share (EPS) was $0.02, compared with $-0.01 in 2024.
How has JMS Co.,Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, JMS Co.,Ltd.'s earnings per share (EPS) went from $0.75 to $0.02, an average decline of 51.56% a year.
How does JMS Co.,Ltd.'s earnings per share (EPS) compare with similar companies?
JMS Co.,Ltd.'s earnings per share (EPS) ($-0.18) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.